Evidence map›Paper›PMID 28793143›Full record

ArticleJAMA cardiology2017

Intraoperative Diagnosis of Anderson-Fabry Disease in Patients With Obstructive Hypertrophic Cardiomyopathy Undergoing Surgical Myectomy.

Franco Cecchi, Maria Iascone, Niccolò Maurizi, Laura Pezzoli, Irene Binaco, Elena Biagini, Maria Laura Fibbi, Iacopo Olivotto, Federico Pieruzzi, Ana Fruntelata and 3 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in JAMA cardiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Cardiac magnetic resonance in Fabry disease.European heart journal supplements : journal of the European Society of Cardiology · 2023
    Article
  9. Echocardiography in Anderson-Fabry Disease.Reviews in cardiovascular medicine · 2022
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Franco CecchiCenter for Hypertrophic Cardiomyopathy and Valvular Cardiopathies, Monza Hospital, Monza, Italy.
Maria IasconeMedical Genetics Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy.
Niccolò MauriziReferral Center for Cardiomyopathies, Careggi University Hospital, Florence, Italy.
Laura PezzoliMedical Genetics Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy.
Irene BinacoCenter for Hypertrophic Cardiomyopathy and Valvular Cardiopathies, Monza Hospital, Monza, Italy.
Elena BiaginiCardiology, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, Sant'Orsola-Malpighi Polyclinic, Bologna, Italy.
Maria Laura FibbiAnatomy and Histopathology Laboratory, Monza Hospital, Monza, Italy.
Iacopo OlivottoReferral Center for Cardiomyopathies, Careggi University Hospital, Florence, Italy.
Federico PieruzziNephrology and Dialysis Unit, San Gerardo Hospital, Monza, Italy.
Ana FruntelataCardiomyopathy Center, Monza Hospital, Bucharest, Romania.
Lucian DorobantuCardiomyopathy Center, Monza Hospital, Bucharest, Romania.
Claudio RapezziCardiology, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, Sant'Orsola-Malpighi Polyclinic, Bologna, Italy.
Paolo FerrazziCenter for Hypertrophic Cardiomyopathy and Valvular Cardiopathies, Monza Hospital, Monza, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITClinical Emergency Hospital Bucharest · ROOspedale Papa Giovanni XXIII · ITPoliclinico S.Orsola-Malpighi · ITAzienda Ospedaliera San Gerardo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Diagnostic screening for Anderson-Fabry cardiomyopathy (AFC) is performed in the presence of specific clinical red flags in patients with hypertrophic cardiomyopathy (HCM) older than 25 years. However, left ventricular outflow tract obstruction (LVOTO) has been traditionally considered an exclusion criteria for AFC. Objective: To examine a series of patients diagnosed with HCM and severe basal LVOTO undergoing myectomy in whom the diagnosis of AFC was suspected by the cardiac surgeon intraoperatively and confirmed by histological and genetic examinations. Design, Setting, and Participants: This retrospective analysis of patients undergoing surgical septal reduction strategies was conducted in 3 European tertiary referral centers for HCM from July 2013 to December 2016. Patients with a clinical diagnosis of obstructive HCM referred for surgical management of LVOTO were observed for at least 18 months after the procedure (mean [SD] follow-up, 33 [14] months). Main Outcomes and Measures: Etiology of patients with HCM who underwent surgical myectomy. Results: From 2013, 235 consecutive patients with a clinical diagnosis of HCM underwent septal myectomy. The cardiac surgeon suspected a storage disease in 3 patients (1.3%) while inspecting their heart samples extracted from myectomy. The mean (SD) age at diagnosis for these 3 patients was 42 (4) years; all were male. None of the 3 patients presented with extracardiac features suggestive of AFC. All patients showed asymmetrical left ventricular hypertrophy, with maximal left ventricular thickness in the basal septum (19-31 mm), severe basal LVOTO (70-120 mm Hg), and left atrial dilatation (44-57 mm). Only 1 patient presented with late gadolinium enhancement on cardiovascular magnetic resonance at the right ventricle insertion site. The mean (SD) age at surgical procedure was 63 (5) years. On tactile sensation, the surgeon felt a spongy consistency of the surgical samples, different from the usual stony-elastic consistency typical of classic HCM, and this prompted histological examinations. Histology showed evidence of intracellular storage, and genetic analysis confirmed a GLA A gene mutation (p.Asn215Ser) in all 3 patients. Conclusions and Relevance: Screening for AFC should be performed even in the absence of red flags in patients with HCM older than 25 years.

Indexed as

AdultCardiac Surgical ProceduresCardiomyopathy, HypertrophicCarrier ProteinsEchocardiography, DopplerFabry DiseaseHumansIncidental FindingsMaleMutationMyosin Binding Protein CPedigreePreoperative CareRetrospective StudiesCarrier ProteinsMyosin Binding Protein C

Identifiers

PMID28793143
PMCPMC5815007
OpenAlexW2745295054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.